• Clinical and Experimental Pediatrics
• /
• 제49권3호
• /
• pp.305-311
• /
• 2006

목 적 : 성조숙증은 사춘기가 일찍 발생함으로써 최종성인키의 저하가 초래되는 질환으로 사춘기 발현을 억제하여 최종성인키를 향상시키기 위하여 사용되는 성선자극호르몬방출호르몬유도체(gonadotropin releasing hormone agonist, GnRHa)와 일부환자에서 병합치료로 이용되는 성장호르몬(GH)의 치료 효과를 알아보고자 하였다. 방 법 : 1989-2003년까지 서울대학교병원 소아과에서 특발성진성 성조숙증으로 진단 받고 2년 이상 GnRHa를 투여한 21명과 성장호르몬의 병합치료를 시행한 9명에 대하여 2년간의 성장 속도, 예측성인키(predicted adult height, PAH)를 조사하였으며, GnRHa만 투여받은 15명과 성장호르몬을 병합투여받은 6명에서 최종성인키 차이를 후향적으로 비교 분석하였다. 모든 분석은 GnRHa 치료 전 예측성인키가 중간부모키-5 cm(성인여성의 키 1 표준편차)보다 작은 군(PAH_L)과 큰 군(PAH_H), 성장호르몬 병합치료군(GnRHa+GH)으로 구분하여 시행하였다. 결 과 : GnRHa 치료에 따른 PAH의 증가는 PAH_L군에서 첫 1년 동안에 관찰되어, PAH(키 SDS)는 치료 시작 시 $149.7{\pm}6.4cm(-2.1{\pm}1.3)$에서 1년 후에는 $153.5{\pm}6.5cm(-1.4{\pm}1.3)$로 유의하게 증가하고(P=0.004), 2년째에는 $155.8{\pm}8.0cm(-0.9{\pm}1.6)$이었다. 이 시기 동안에 성장속도는 $6.2{\pm}0.7cm$/년이였으며, 골연령 증가(골연령-역연령) 정도는 변화가 없었다. PAH_H군에서는 치료 전 PAH(키 SDS) $160.0{\pm}4.4cm(-0.1{\pm}0.9)$에서 변화가 없어 2년째 $159.5{\pm}6.0cm(-0.2{\pm}1.2)$였다. GnRHa+GH군은 첫 GnRHa 치료시의 PAH는 $149.4{\pm}7.8cm$로 PAH_L군과 비슷하며, 평균 2.3년 동안 GnRHa로 치료받은 후 PAH(키 SDS)는 $154.0{\pm}5. cm(-1.7{\pm}0.9)$로 증가하였으나(P=0.065), GnRHa 투여군들과는 차이가 없었다. 성장호르몬을 병합 투여한 후에 첫 1년 동안 성장속도가 $8.0{\pm}2.8cm/yr$로 치료 전 성장속도 $4.7{\pm}1.2cm/yr$에 비하여 유의하게 증가하여(P=0.013), 결국 1년째 PAH(키 SDS)가 $159.6{\pm}4.4cm(-0.4{\pm}0.6)$로 병합치료 전에 비하여 유의하게 증가하였으며, 2년째는 증가보다는 유지되는 정도였다. PAH_L군(N=8)의 최종성인키(키 SDS)는 $159.8{\pm}5.2cm(-0.1{\pm}1)$로 치료 전에 비하여 $8.5{\pm}2.2cm$ 커졌으며(P<0.001), PAH_H군(N=7)의 최종성인키(키 SDS)는 $156.5{\pm}5.1cm(-0.8{\pm}1)$로 치료 전 예측성인키(SDS) $158.6{\pm}3.8cm(-0.4{\pm}0.8)$, 중간부모키 $157.9{\pm}5.1cm(-0.4{\pm}0.9)$와 차이가 없었다. GnRHa+GH군(N=6)의 최종성인키(키 SDS)는 $158.7{\pm}3.7cm(-0.3{\pm}0.7)$로 GnRHa 치료 전 및 성장호르몬 병합치료 전 예측성인키(키 SDS)에 비하여 각각 평균 11.8 cm, 6.2 cm 증가하였으며(P<0.05), 중간부모키와 비슷하였다. 결 론 : GnRHa 투여의 효과는 첫 1년째에 중간부모키에 비하여 치료 전 예측성인키가 작은 환자에서 뚜렷하게 나타나며, GnRHa 투여 중 성장속도가 저하되면서 예측성인키와 중간부모 키가 작은 환자에서 성장호르몬을 병합 투여하면 중간부모키와 비슷한 최종성인키를 얻을 수 있을 것으로 사료된다.

• 농촌계획
• /
• 제22권1호
• /
• pp.57-67
• /
• 2016

The purpose of this study was to review of animal-assisted therapy. Method: Animal-assisted therapies (AATs) in domestic and international studies (68 cases) were analyzed by searching databases, KERIS & KISS, and the Pub MED(NCBI). Result: In AATs, a few animals were used for the various disease or disorder. Dog centered therapies were most common.. AATs were used in the various disorder and disease. For the psychological effect, majority of the outcome variables were depression and anxiety. For the physical effect, the most outcome variables were blood pressure, heart rate, and stress hormone. However, These results show that AATs were confined to specific areas such as sensation-centered therapies. Conclusion: AATs had positive effects both in physical and psychological factors even if the study areas have not been applied to the various condition. The further research is needed to identify scientific grounds for the effects of the interventions through various therapies.

• 대한정형도수물리치료학회지
• /
• 제15권2호
• /
• pp.93-97
• /
• 2009

Anatomy: Facet joint syndrome most often affects the lower back and neck and refers to pain that occurs in the facet joints, which are the connections between the vertebrae in the spine that enable the spine to bend and twist. Many physicians have believed that the usual lesion of facet syndrome was an anatomical impairments of facet joint itself.. Facet joint injection using local anesthetics is a reliable method for the diagnosis and treatment for facet syndrome. Etiology: One of many possible causes is imbalances that can occur in stress levels, hormone levels, and nutritional levels. These imbalances can adversely affect posture, which can lead to neck and back pain. The common disorder called facet syndrome exhibits lower back pain, with or without, radiating pain to buttock and thigh due to facet joint arthropathy. Pain in the facet joint is supposedly the secondary effect of narrowing of joint space by sustained muscle contracture around joints. Syndrome: Facet joint syndrome tends to produce pain or tenderness in the lower back that increases with twisting or arching the body, as well as pain that moves to the buttocks or the back of the thighs. Other symptoms include stiffness or difficulty standing up straight or getting out of a chair. Pain can be felt in other areas such as the shoulders or mid-back area. Treatment: Non-drug treatments include hot packs, ultrasound, electrical stimulation, and therapeutic exercises. Stimulating blood flow using massage or a hot tub may also help. Alternative treatments include yoga and relaxation therapy. If your pain persists after trying these treatments, a surgical procedure called radiofrequency rhizotomy, which destroys the sensory nerves of the joint, may bring relief. Facet joint injection has been helpful in diagnosis and therapy for this facet syndrome. Radiofrequency thermocoagulation of medial branches is known to be an effective method of relieving pain caused by facet joint problems. We conclude that spasmolytic treatment of muscles connecting the two vertebral articular space would be better for treatment and diagnosis of facet syndrome rather than facet block with local anesthetic and steroid only.

• Clinical and Experimental Pediatrics
• /
• 제52권11호
• /
• pp.1249-1259
• /
• 2009

목 적:소아 성장호르몬결핍증의 저신장 치료에 사용되는 성장호르몬 생물학적 제제인 서방형 주사제의 비용-효과성을 사회적 관점에서 기존 매일 주사제와 비교하여 평가하고자 한다. 방 법:성장 호르몬 치료를 받는 환아를 대상으로 시각화 척도 방법에 의해 건강 관련 효용을 측정하였다. 2008년 7월, 이 연구에 참여한 2개 병원에서 저성장증 치료를 받고 있는 149명의 환아 보호자에게 매일 주사제에 대한 효용과 주 1회 주사제를 사용할 경우 기대되는 효용을 인터넷을 통해 설문조사 하였다. 성장호르몬 주사요법 중 매일 주사제와 주 1회 주사제 투여에 소요되는 직․간접 비용은 차이가 없으므로, 두 제형의 의약품비만을 비교하였다. 결 과:매일 주사제에서 주 1회 주사제로 전환할 경우 예상되는 효용값은 0.584에서 0.784로 증가하며, 연평균 추가비용은 4,060,811원이 발생한다. 점증적 비용-효용비는 20,304,555원/QALY (quality-adjusted life year gained)로 계산되었다. 시나리오 분석 결과, 점증적 비용-효용비는 최소 15,751,198원/QALY에서 최대 25,489,929원/QALY이다. 결 론:Base case 및 시나리오 분석결과에서 제시하는 점증적 비용-효용비는 우리 나라 1인당 GDP의 0.85-1.37배 범위 내에 있으므로 매우 안정적으로 비용-효과성이 있는 것으로 판단된다. 따라서, 매일 주사제에서 주1회 주사제로의 투약방법 변경은 비용-효과적이라 할 수 있으며, 주 1회 주사제가 추가 비용을 부담하더라도 경제성이 우수하다고 결론지을 수 있다.

• Clinical and Experimental Pediatrics
• /
• 제56권6호
• /
• pp.260-264
• /
• 2013

Dapsone (4,4'-diaminodiphenylsulfone, DDS), a potent anti-inflammatory agent, is widely used in the treatment of leprosy and several chronic inflammatory skin diseases. Dapsone therapy rarely results in development of dapsone hypersensitivity syndrome, which is characterized by fever, hepatitis, generalized exfoliative dermatitis, and lymphadenopathy. Here, we describe the case of an 11-year-old Korean boy who initially presented with high fever, a morbilliform skin rash, generalized lymphadenopathy, hepatosplenomegaly, and leukopenia after 6 weeks of dapsone intake. Subsequently, he exhibited cholecystitis, gingivitis, colitis, sepsis, aseptic meningitis, disseminated intravascular coagulation, syndrome of inappropriate antidiuretic hormone secretion, pneumonia, pleural effusions, peritonitis, bronchiectatic changes, exfoliative dermatitis, and acute renal failure. After 2 months of supportive therapy, and prednisolone and antibiotic administration, most of the systemic symptoms resolved, with the exception of exfoliative dermatitis and erythema, which ameliorated over the following 4 months. Agranulocytosis, atypical lymphocytosis, aseptic meningitis, and bronchiectatic changes along with prolonged systemic symptoms with exfoliative dermatitis were the most peculiar features of the present case.

• Clinical and Experimental Pediatrics
• /
• 제60권2호
• /
• pp.31-37
• /
• 2017

Steroid 21-hydroxylase deficiency is the most prevalent form of congenital adrenal hyperplasia (CAH), accounting for approximately 95% of cases. With the advent of newborn screening and hormone replacement therapy, most children with CAH survive into adulthood. Adolescents and adults with CAH experience a number of complications, including short stature, obesity, infertility, tumor, osteoporosis, and reduced quality of life. Transition from pediatric to adult care and management of long-term complications are challenging for both patients and health-care providers. Psychosocial issues frequently affect adherence to glucocorticoid treatment. Therefore, the safe transition of adolescents to adult care requires regular follow-up of patients by a multidisciplinary team including pediatric and adult endocrinologists. The major goals for management of adults with 21-hydroxylase deficiency are to minimize the long-term complications of glucocorticoid therapy, reduce hyperandrogenism, prevent adrenal or testicular adrenal rest tumors, maintain fertility, and improve quality of life. Optimized medical or surgical treatment strategies should be developed through coordinated care, both during transition periods and throughout patients' lifetimes. This review will summarize current knowledge on the management of adults with CAH, and suggested appropriate approaches to the transition from pediatric to adult care.

• 턱관절균형의학회지
• /
• 제9권1호
• /
• pp.24-34
• /
• 2019

울산광역시 동구 보건소 협력 사업으로 한 2014년도 한방 난임 치료 1증례를 포함한 6증례중에서 난임의 치료방법으로 4증례는 FCST의 편차수정, 음양균형장치를 포함한 PBT, 침 치료, 부항, 뜸, 한약 등의 복합치료로 전신 증상의 개선 및 감소에 현저한 치료효과가 나타남을 관찰하였다. 2증례는 음양균형장치와 PBT는 제외되었다. 또한 그 결과로 6증례 모두 자연 임신에 성공하여 출산하였고 출산한 아기들도 건강한 상태임을 확인하였다.

• 종양간호연구
• /
• 제12권1호
• /
• pp.12-19
• /
• 2012

Purpose: To examine the levels of physical activity (PA) and diet quality, socio-demographic and clinical correlates, and identify associations with health-related quality of life (HRQOL) among breast cancer survivors. Methods: The study used a cross-sectional study design. A total of 74 breast cancer survivors who had completed their primary cancer therapy were recruited from a comprehensive cancer center in Korea. Measurements used included the International Physical Activity Questionnaire, the Diet Quality Index, and the EORTC QLQ-C30. Results: Only twenty-six women (35.1%) met the American Cancer Society criteria of weekly PA, while most participants (93.2%) displayed good or excellent diet quality. Those less likely to meet the PA criteria were older women, women who had a lower economic level, and women not receiving anti-hormone therapy. However, there was no significant factor associated with diet quality. Women who met the criteria for PA displayed significantly better global QOL than women who did not meet the criteria. No significant differences were found in HRQOL between women who did and did not meet the diet quality criteria. Conclusion: Nurses should be aware of breast cancer survivors who are older and who have a low economic status when assessing and screening the level of PA to improve HRQOL.

• 대한한방소아과학회지
• /
• 제13권1호
• /
• pp.17-62
• /
• 1999

Recently lots of books on the process of growing have been published on adolescence and their parents hope to grow tall but yet lacked the correct knowledge. Before helping the growth of body, the best way is to do away with the check factors of the human body. Therefore oriental and occidental medicine study on the inhibition of growth and the result of case study about life therapy, kinesiatrics, including medical therapy are as follows: The habits that help the process of growing are deep sleep, balanced diets, daily physical exercise, good posture. It is essential for people to relieve stress. The physical exercises that promote the process of growing are as follows: to stretch out, daily suitable exercise which stimulates the metabolism of human body to increase levels of growth hormone and excite growth plate, to hasten the process of growing, Oriental medicine causes on the inhibition of growth show many factors: kidney trouble is the inhibited cause, spleen ailment is the acquired ground. The lack of essence of the dual principal of the negative and the positive makes people the inhibition of growth. All these things including fire and dryness have close relations.

• Journal of Yeungnam Medical Science
• /
• 제40권1호
• /
• pp.12-22
• /
• 2023

Graves disease (GD) is the most common cause of hyperthyroidism, accounting for more than 90% of cases in Korea. Patients with GD are treated with any of the following: antithyroid drugs (ATDs), radioactive iodine (RAI) therapy, or thyroidectomy. Most patients begin treatment with ATDs, and clinical guidelines suggest that the appropriate treatment period is 12 to 18 months. While RAI treatment and surgery manage thyrotoxicosis by destroying or removing thyroid tissue, ATDs control thyrotoxicosis by inhibiting thyroid hormone synthesis and preserving the thyroid gland. Although ATDs efficiently control thyrotoxicosis symptoms, they do not correct the main etiology of GD; therefore, frequent relapses can follow. Recently, a large amount of data has been collected on long-term ATDs for GD, and low-dose methimazole (MMZ) is expected to be a good option for remission. For the long-term management of recurrent GD, it is important to induce remission by evaluating the patient's drug response, stopping ATDs at an appropriate time, and actively switching to surgery or RAI therapy, if indicated. Continuing drug treatment for an extended time is now encouraged in patients with a high possibility of remission with low-dose MMZ. It is also important to pay attention to the quality of life of the patients. This review aimed to summarize the appropriate treatment methods and timing of treatment transition in patients who relapsed several times while receiving treatment for GD.